Matthias Magoola Archives

A photo collage of Uganda's powerful businessmen; Simba Group's Patrick Bitature, Hamis Kiggundu of Ham Group of Companies, Kampala International University Proprietor, Hassan Basajjabalaba and Dei BioPharma's Mathias Magoola.

Debt, Deals & Disputes: Inside the High-Stakes Legacy-Altering Legal Battles of Ugandan Billionaires — Bitature, Basajjabalaba and Dei’s Magoola

The past five years have not gone particularly well for Uganda’s billionaire class. Once the undisputed symbols of local enterprise and ambition, several of the country’s most prominent businessmen have found themselves

November 10, 2025

Legal & Justice·News & Analysis·The Big Story

Dei's Matthias Magoola (left) has hired lawyer, Fred Muwema (centre) to sue Equity Bank, represented by the Managing Director, Anthony Kituuka (right).

EXCLUSIVE: Despite receiving UGX578 bn from the gov’t Dei BioPharma’s Magoola refuses to pay Equity Bank and instead sues the bank

Despite having received UGX578.4 billion (USD million) in capitalisation from the government of Uganda, part of which was to be used to settle his indebtedness with Equity Bank, controversial pharma-entrepreneur, Matthias Magoola

August 7, 2024

News & Analysis·The Big Story

President Museveni launches Dei Biopharma’s pharmaceutical manufacturing plant

President Yoweri Museveni, on Friday, October 21, commissioned the Dei Biopharma manufacturing facility in Matugga, near Kampala. The pharmaceutical plant will produce high-quality yet affordable medicines across a range of therapeutic areas

October 22, 2022

Company News·News & Analysis·The Big Story

Matthias Magoola, Managing Director Dei Minerals International

ABUSE OF COURT PROCESS: High Court quashes warrant of arrest issued by registrar in Dei Minerals boss dispute with ex-minister Musumba

The High Court in Kampala has quashed a warrant of arrest issued against the managing director of Dei Minerals International, Matthias Magoola, in which former Isaac Musumba sought to be paid UGX268

September 7, 2022

News & Analysis

DEI Biopharma is expected to produce all of the biologic medicines listed as essential drugs

Dei Biopharma awaits approvals on first Covid-19 medicine produced in Uganda

MATUGGA – Dei Biopharma is awaiting approval of the World Health Organisation (WHO) to out it’s Molnupiravir drug, which will be the first such product to treat Covid-19 infection in the world.DEI

March 9, 2022

News & Analysis·The Big Story

President Museveni (Right) during the launch of the construction of the Dei Natural Products International Ltd plant in Matugga on June 3, 2020

Pharmaceutical Company pins Mutoni Construction (U) Ltd for Breach of Terms

A company, setting up a pharmaceutical plant at Matugga on Bombo Road, on the outskirts of Kampala, has pinned a South African contractor of breaching terms and instead resorting to using politicians

January 4, 2022

Company News·News & Analysis